#Leqselvi is approved to treat adults with severe #alopecia. One-third of patients in clinical trials experienced 80% scalp hair coverage at 24 weeks. #FDA https://lnkd.in/eUBNN_gH
About us
As a healthcare executive in this ever-changing industry, we know how hard your job can be. Founded in 1990, Managed Healthcare Executive helps you stay informed by providing updates on all of the industry changes and innovations, which will help you make the best decisions for your organization and patient care.
- Website
-
http://www.managedhealthcareexecutive.com/
External link for Managed Healthcare Executive
- Industry
- Media Production
- Company size
- 2-10 employees
- Headquarters
- North Olmsted, Ohio
- Type
- Public Company
- Founded
- 1990
- Specialties
- print magazine, online publication, and eNewsletter
Locations
-
Primary
24950 Country Club Blvd.
Suite 200
North Olmsted, Ohio 44133, US
Employees at Managed Healthcare Executive
-
Marci J Chodroff, MD, FACP
Physician Executive | Vice President, Medical Affairs at Magellan Rx Management, a Prime Therapeutics company| HBA Luminary
-
John Mathewson
Chief Operating Officer, AHIP // Health Industry Leader
-
Will Meyers
Partners with Manufacturers to Enhance Market Access Marketing & Strategy | Senior National Accounts Manager @ Managed Healthcare Executive
Updates
-
Phase 3 trials reported at the International AIDS Society meeting this week show no infections among those randomly assigned to twice-year injections of lenacapavir and no reason to be worried about safety. #HIV2024 https://lnkd.in/eT_xbnhM
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift | AIDS 2024
managedhealthcareexecutive.com
-
Experts discuss common symptoms of idiopathic pulmonary fibrosis (IPF), analyze how the disease progresses over time and examine the overall economic burden IPF patients face. Watch this K-Cast series to learn more about IPF and its impact: https://bit.ly/3VYeOSZ #ManagedCare paul noble
-
-
The HIV vaccine field has recently faced setbacks with trials like #PrepVacc, #Mosaico and #Imbokodo ending early due to lack of preventive efficacy. Although there have been challenges, scientists have made discoveries showing that the immune system can be prepared to fight HIV with special antibodies. #HIV2024 https://lnkd.in/eih_Nsju
A Renewed Commitment to HIV Vaccine Development Despite Advancements in Antiretrovirals | AIDS 2024
managedhealthcareexecutive.com
-
An overview of the complex relationships between herpes simplex virus, human papillomavirus, cytomegalovirus and HIV. #AIDS2024 #HIV https://lnkd.in/eiSAcvFi
Chronic Viral Infections Common in Those with HIV | AIDS 2024
managedhealthcareexecutive.com
-
Results from the BEYOND trial show positive clinical outcomes and patient experiences. #AIDS2024 https://lnkd.in/gZ6qHRda
Thumbs-Up Results for Injectable Cabenuva in the Real World | AIDS 2024
managedhealthcareexecutive.com
-
Younger transgender and gender diverse individuals see a greater stigma around #PrEP, but experts are still unsure why. #HIVPrEP #HIV https://lnkd.in/gpgiJ5Wx
Increased PrEP Stigma in Gender Diverse Individuals | AIDS 2024
managedhealthcareexecutive.com
-
A substudy of the FLAIR phase 3 trial found that participants favored intramuscular injection of #Cabenuva over the subcutaneous version due to pain and the development of nodules and reddening of the skin. #HIV #AIDS2024 https://lnkd.in/gEE3qwnV
ViiV Healthcare Will Not Continue Trials of Subcutaneous Cabenuva | AIDS 2024
managedhealthcareexecutive.com
-
Despite substantial progress in reducing vertical transmission from mothers to children, efforts to curtail the HIV/AIDS among children and adolescents are plateauing in some respect and falling short of the goals set by the Joint United Nations Programme on HIV/AIDS (UNAIDS) , according to a leading investigator of HIV/AIDS treatment of children. #AIDS2024 https://lnkd.in/gcaSFjcu
Pediatric AIDS: Progress But Then a Plateau | AIDS 2024
managedhealthcareexecutive.com
-
At the 25th annual international AIDS Conference in Munich, Germany, a group of international experts discussed the impact of HIV-related stigma and discrimination on efforts to end the #HIV pandemic as a public health threat by 2030. #AIDS2024 https://lnkd.in/ex5y7S3S
Ongoing Stigma Remains a Major Obstacle in the Fight Against HIV | AIDS 2024
managedhealthcareexecutive.com